Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- BAYER CORP
- Publication Date
- 2004-08-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates to 4-amino-5,6-substituted thieno[2,3-d]pyrimidine compounds, pharmaceutical compositions containing said compounds, and said compounds in the treatment or prevention of phosphodiesterase 7 B (PDE7 B )-mediated diseases and conditions. by PDE7 B Mediated diseases and conditions include osteoporosis, osteopenia, and asthma. The present invention also relates to methods of preparing 4-amino-5,6-substituted thieno[2,3-d]pyrimidine compounds, and methods of preparing compositions containing said compounds. Background of the invention
[0002] Cyclic nucleotide phosphodiesterase (PDE) exhibits specificity for purine cyclic nucleotide substrates and catalyzes the hydrolysis of cyclic AMP (cAMP) and cyclic GMP (cGMP) (Thompson, W.J. (1991) Pharma.Ther.51 :13-33). Cyclic nucleotide phosphodiesterases regulate steady-state levels of cAMP and cGMP and regulate the magnitude and duration of cyclic nucleotide signaling. These...